万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>肿瘤学

The Cancer Journal《癌症杂志》 (官网投稿)

简介
  • 期刊简称CANCER J
  • 参考译名《癌症杂志》
  • 核心类别 SCIE(2024版), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率0.30%
  • 主要研究方向医学-ONCOLOGY肿瘤学

主要研究方向:

等待设置主要研究方向
医学-ONCOLOGY肿瘤学

The Cancer Journal《癌症杂志》(双月刊). The Cancer Journal: The Journal of Principles & Practice of Oncology provides an integrated view of...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://journals.lww.com/journalppo/pages/default.aspx

3、投稿网址:

https://www.editorialmanager.com/ppo/

4、官网邮箱:anngrego@med.umich.edu(总编)

5、期刊刊期:双月刊,一年出版6期。

2022112日星期三

                              

 

投稿须知【官网信息】

 

The Cancer Journal: The Journal of Principles & Practice of Oncology

Scope. The Cancer Journal: The Journal of Principles & Practice of Oncology provides an integrated view of modern oncology across all disciplines. The Journal publishes original research and reviews, and keeps readers current on content published in the book Cancer: Principles & Practice of Oncology. In addition, readers may submit questions which will be answered in the Journal. Edited by the same team as the classic book, The Cancer Journal is a premier educational resource.

The Cancer Journal is published bimonthly and considers original articles in English relating to all aspects of oncology, including clinical aspects; medical, surgical, and radiation therapies; and research from basic science disciplines that has implications for oncology. The Editors are particularly interested in manuscripts that offer a multidisciplinary approach, discuss new modalities, or emphasize translational research.

Ethical/Legal Considerations. A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.

Conflicts of interest

Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared.  All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:“. For example:

Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.

In addition, each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).

A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.

Permissions:

For permission and/or rights to use content for which the copyright holder is LWW or the society, please go to the journal's website and after clicking on the relevant article, click on the "Request Permissions" link under the "Article Tools" box that appears on the right side of the page. Alternatively, send an e-mail to customercare@copyright.com.

For Translation approval, License to republish and distribute, or Permission to reuse material in another publication or presentation, please email one of the following:

TranslationRights@wolterskluwer.com

HealthLicensing@wolterskluwer.com

HealthPermissions@wolterskluwer.com

For Special Projects and Reprints (non-U.S./Canada), contact Silvia Serra, Translations Rights, Licensing & Permissions Manager, Wolters Kluwer Health (Medical Research) Ltd, 250 Waterloo Road, London SE1 8RD, UK. Phone: +44 (0) 207 981 0600. E-mail: silvia.serra@wolterskluwer.com

Online Manuscript Submission. Manuscripts should be submitted online through the Journal Editorial Website (http://ppo.edmgr.com).

First-time users: Please click the Register button from the main menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, re-registration is unnecessary, even if your status changes (that is, author, reviewer, or editor).

Authors: Please click the login button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Annette Gregory, Managing Editor (anngrego@med.umich.edu).

Journal Contents. Please follow guidelines for article length carefully. If accepted articles exceed recommended length, authors will be required to shorten their articles before publication. In addition, the total number of illustrations (sum of tables and figures) may not exceed half of the number of typed text pages minus one. For example, an article with 15 text pages is limited to a total of 7 illustrations and/or tables.

Original Articles: Original articles describing new findings of major importance are invited for submission. Articles should contain no more than 4,000 words of text.

……

更多详情:

https://edmgr.ovid.com/ppo/accounts/ifauth.htm


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭